한빛사논문
Ha, Jeong Hyun MD, MSa,b; Ahn, Seoin BSc; Kim, Hong-Kyu MD, PhDd; Lee, Han-Byoel MD, PhDd,e,f; Moon, Hyeong-Gon MD, PhDd,g; Han, Wonshik MD, PhDd,e,f; Hong, Ki Yong MD, PhDb; Chang, Hak MD, PhDb,h; Lee, Gordon K. MD, FACSi; Choi, Jinwook MD, PhDa,j; Jin, Ung Sik MD, PhDb,h
aInterdisciplinary Program of Medical Informatics, Seoul National University College of Medicine, Seoul, South Korea
bDepartment of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul, South Korea
cInterdisciplinary Program of Bioengineering, Seoul National University College of Medicine, Seoul, South Korea
dDepartment of Surgery, Seoul National University Hospital, Seoul, South Korea
eCancer Research Institute, Seoul National University, Seoul, South Korea
fBiomedical Research Institute, Seoul National University Hospital, Seoul, South Korea
gGenomic Medicine Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, South Korea
hDepartment of Plastic and Reconstructive Surgery, Seoul National University College of Medicine, Seoul, South Korea
iDivision of Plastic Surgery, Department of Surgery, Stanford University Medical Center, CA, USA
jDepartment of Biomedical Engineering, Seoul National University College of Medicine, Seoul, South Korea
Jinwook Choi, Ung Sik Jin These two authors contributed equally to this work.
*Corresponding authors: Jinwook Choi, Ung Sik Jin
Abstract
Background: Infections following postmastectomy implant-based breast reconstruction (IBR) can compromise surgical outcomes and lead to significant morbidity. This study aimed to discern the timing of infections in two-stage IBR and associated risk factors.
Method: A review of electronic health records was conducted on 1,096 breasts in 1,058 patients undergoing two-stage IBR at ** National University Hospital (2015-2020). Infections following the first-stage tissue expander (TE) insertion and second-stage TE exchange were analyzed separately, considering associated risk factors.
Results: Over a median follow-up of 53.5 months, infections occurred in 2.9% (32/1096) after the first stage and 4.1% (44/1070) after the second stage. Infections following the first-stage procedure exhibited a bimodal distribution across time, while those after the second-stage procedure showed a unimodal pattern. When analyzing risk factors for infection after the first-stage procedure, axillary lymph node dissection (ALND) was associated with early (≤7 weeks) infection, while both ALND and obesity were independent predictors of late (>7 weeks) infection. For infections following the second-stage procedure, obesity, postmastectomy radiotherapy, a history of expander infection, ALND, and the use of textured implants were identified as independent risk factors. Postmastectomy radiotherapy was related to non-salvaged outcomes after infection following both stages.
Conclusion: Infections following first and second-stage IBR exhibit distinct timelines reflecting different pathophysiology. Understanding these timelines and associated risk factors will inform patient selection for IBR and aid in tailored postoperative surveillance planning. These findings contribute to refining patient suitability for IBR and optimizing personalized postoperative care strategies.
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기